Results of the Cox regression model showing predictors of attrition from HIV care among HIV infected adults on cART.

<p>^a at enrolment in HIV care.</p><p>^b at start cART.</p><p>^c according to the revised World Health Organization clinical staging of HIV/AIDS for adults and adolescents, 2005 [<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0130649#pone.0130649.ref051" target="_blank">51</a>].</p><p>d4T, Stavudine; AZT, Zidovudine; TDF, Tenofovir.</p><p>HR, hazard ratio.</p><p>* p-value < 0.2.</p><p>^‡ p-value < 0.05.</p><p>1 = reference category.</p><p>Results of the Cox regression model showing predictors of attrition from HIV care among HIV infected adults on cART.</p

Flowchart depicting the random selection of health care facilities and patients included in the study.

<p>Flowchart depicting the random selection of health care facilities and patients included in the study.</p

Patients’ socio-demographic, clinical, and treatment characteristics (n = 836).

<p>* values are n (%) unless otherwise indicated.</p><p>^a at enrolment in HIV care.</p><p>^b at start cART.</p><p>^c at study entry or at last known clinic/pharmacy refill visit date.</p><p>^d according to the revised World Health Organization clinical staging of HIV/AIDS for adults and adolescents, 2005 [<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0130649#pone.0130649.ref051" target="_blank">51</a>].</p><p>TDF, Tenofovir; AZT, Zidovudine; d4T, Stavudine.</p><p>SD, standard deviation; IQR, inter-quartile range.</p><p>Patients’ socio-demographic, clinical, and treatment characteristics (n = 836).</p